The expression and activity of BK channels, the major inhibitors of DSM excitability and contractility, have been reported to be reduced in the DSM of patients with OAB resulting from benign prostatic hyperplasia and neurogenic bladder dysfunction [27, 28]. Here, KCNMA1 is linked to benign prostatic hyperplasia.